Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer
BMC Pulmonary Medicine Dec 19, 2017
Kumagai S, et al. - This study involved the development and validation of a novel preoperative prognostic tool for patients with resected non-small cell lung cancer (NSCLC). Based on 7 variables, this simple pre-operative prognostic index, as proposed and validated in this study, may serve as a helpful tool for predicting prognosis before surgery in patients with NSCLC.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
